Search filters

List of works by Luminita Schneider

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients

scientific article

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.

scientific article

Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1.

scientific article

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

scientific article published in December 2003

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

scientific article published on 19 July 2013

Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs

scientific article

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

scientific article

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug

scientific article published on 27 August 2009

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.

scientific article published on 28 September 2012

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure

scientific article published on 19 September 2014

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

scientific article

Paulina is supported by:

About Paulina

Help